Author:
Kingsberg Sheryl A.,Althof Stanley E.
Subject
Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health
Reference32 articles.
1. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Draft guidance for industry: Female sexual dysfunction: Clinical development of drug products for treatment. 2000; Available at: http://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm133202.htm (accessed August 1, 2011).
2. Outcome measurement in female sexual dysfunction clinical trials: Review and recommendations;Althof;J Sex Marital Ther,2005
3. Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment;Clayton;J Sex Med,2010
4. Revicki D, Margolis M, Bush E, Hanes V. Content validity of the Female Sexual Function Index in pre- and postmenopausal women with hypoactive sexual desire disorder. Presented at the 3rd International Consultation on Sexual Medicine. Paris, France, July 10–13, 2009.
5. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome;Nitti;J Urol,2007
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献